Springer Nature [academic journals on nature.com], Leukemia, 2(29), p. 503-507, 2014
DOI: 10.1038/leu.2014.294
Full text: Download
Splenic marginal zone lymphoma (SMZL) is an indolent B-cell tumor involving the spleen, and is characterized by recurrent deletion of chromosome 7q and biased usage of the immunoglobulin heavy variable (IGHV) allele 1-2*04.(1) Genomic studies have partially unraveled the typical SMZL-coding genome, which is characterized by lesions affecting genes involved in the physiological homeostasis of marginal zone (MZ) B cells, including mutations of NOTCH2.(2-5) However, the full spectrum of lesions that contribute to the malignant transformation of SMZL remains unknown.